Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

WT1 and glomerular diseases.

Patrick Niaudet1, Marie-Claire Gubler

  • 1Service de Néphrologie Pédiatrique and INSERM U574, Hôpital Necker-Enfants Malades, 149 rue de Sévres, 75743, Paris, Cedex 15, France. niaudet@necker.fr

Pediatric Nephrology (Berlin, Germany)
|August 24, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome sequencing identifies RMND1 as a strong candidate gene for severe prenatal kidney failure mimicking renal tubular dysgenesis associated with hyporeninism.

Pediatric nephrology (Berlin, Germany)·2025
Same author

How the French national authority for health assesses medicines for use in pediatrics.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2024
Same author

Development of an automated estimation of foot process width using deep learning in kidney biopsies from patients with Fabry, minimal change, and diabetic kidney diseases.

Kidney international·2023
Same author

[History of pediatric nephrology in France].

Medecine sciences : M/S·2023
Same author

Hemolytic-Uremic Syndrome in Children.

Pediatric clinics of North America·2023
Same author

Outcome of infantile nephropathic cystinosis depends on early intervention, not genotype: A multicenter sibling cohort study.

Journal of inherited metabolic disease·2022

Mutations in the WT1 gene cause Denys-Drash and Frasier syndromes, affecting kidney and gonadal development. Understanding these WT1 gene mutations is crucial for diagnosing and managing these rare genetic disorders.

Area of Science:

  • Genetics
  • Molecular Biology
  • Pediatric Nephrology

Background:

  • The WT1 gene is crucial for kidney and gonadal development.
  • Mutations in WT1 are linked to kidney tumors and glomerular diseases.
  • Denys-Drash syndrome (DRS) and Frasier syndrome (FS) are distinct genetic disorders associated with WT1 mutations.

Purpose of the Study:

  • To elucidate the specific roles of WT1 gene mutations in the pathogenesis of Denys-Drash syndrome and Frasier syndrome.
  • To differentiate the mutational mechanisms underlying DRS and FS.
  • To explore the clinical spectrum and genetic transmission of WT1-related disorders.

Main Methods:

  • Analysis of germline mutations in the WT1 gene, including missense mutations in exons 8/9 and intronic mutations affecting +KTS isoforms.

Related Experiment Videos

  • Clinical correlation of identified mutations with patient phenotypes, including kidney disease, gonadal abnormalities, and tumor development.
  • Review of existing literature on WT1-related syndromes.

    • Main Results:

    • Nearly all Denys-Drash syndrome patients harbor WT1 missense mutations in exons 8 or 9, associated with diffuse mesangial sclerosis and Wilms' tumor.
    • All Frasier syndrome patients exhibit intronic WT1 mutations causing loss of +KTS isoforms, leading to focal and segmental glomerulosclerosis and gonadoblastoma.
    • WT1 mutations can present with incomplete syndromes, and Frasier-type mutations have been observed in some Denys-Drash syndrome cases and isolated FSGS.

    Conclusions:

    • WT1 gene mutations are the primary cause of Denys-Drash and Frasier syndromes, with distinct mutation types correlating to specific clinical presentations.
    • The presence or absence of +KTS isoforms due to specific WT1 mutations dictates the progression of kidney disease and gonadal development.
    • Genetic testing for WT1 mutations is essential for accurate diagnosis, risk assessment, and understanding the molecular basis of these complex syndromes.